{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:20:24Z","timestamp":1790198424774,"version":"4.1.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>PCOS is one of the most common endocrine disorders and NAFLD is one of its most dangerous metabolic consequences. The diagnosis of NAFLD is not a practical task and the condition is at risk of being overlooked. The use of simpler but still reliable surrogate markers is necessary to identify women with a high likelihood of NAFLD. The aim of this study was to evaluate the clinical correlates of NAFLD Liver Fat Score (NAFLD-LFS) in women with oligomenorrhea and\/or hirsutism. Furthermore, the study aimed to evaluate whether, among the hormonal parameters evaluated in such women, possible hallmarks of NAFLD may be identified. To this purpose, 66 women who attended our Outpatient Clinic for oligomenorrhea and\/or hyperandrogenism were included in the study. In order to validate the results obtained in the first cohort, a second independent sample of 233 women evaluated for female sexual dysfunction (FSD) was analyzed. In cohort 1, NAFLD-LFS positively correlated with metabolic and inflammatory parameters. Among the hormone parameters, NAFLD-LFS showed no significant relationships with androgens but a significant negative correlation with SHBG (p&amp;lt;0.0001) that therefore appeared as a candidate hallmark for pathologic NAFLD-LFS. The ROC analysis showed a significant accuracy (81.1%, C.I.69.1-93.0, p &amp;lt;0.0001) for SHBG in identifying women with a pathological NAFLD-LFS. In particular, a SHBG 33.4 nmol\/l was recognized as the best threshold, with a sensitivity of 73.3% and a specificity of 70.7%. In order to validate this SHBG as a marker of metabolic impairment possible related with the presence of NAFLD, we tested this threshold in cohort 2. FSD women with SHBG &amp;lt;33.4 nmol\/l had worse metabolic parameters than women with SHBG \u226533.4 nmol\/l and a significantly higher NAFLD-LFS even after adjusting for confounders (B=4.18 [2.05; 6.31], p=0.001). In conclusion, this study provides a new evidence in the diagnostic process of NAFLD, showing that the measurement of SHBG, which is routinely assessed in the workup of women referred for possible PCOS, could identify women at higher metabolic risk, thus detecting those who may deserve further targeted diagnostic assessment.<\/jats:p>","DOI":"10.3389\/fendo.2021.641446","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T17:13:15Z","timestamp":1617037995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and\/or Hirsutism and in Women With Sexual Dysfunction"],"prefix":"10.3389","volume":"12","author":[{"given":"Vincenza","family":"Di Stasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Maseroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Scavello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Todisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Marchiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Sorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Fambrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vignozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2174\/13816128130303","article-title":"From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights","volume":"19","author":"De Minicis","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091955","article-title":"NAFLD: Is There Anything New under the Sun","volume":"18","author":"Lonardo","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14709","article-title":"Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang","year":"2020","journal-title":"Intern Med J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0870","article-title":"Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy","volume":"94","author":"Cussons","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e23235","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis","volume":"14","author":"Ramezani-Binabaj","year":"2014","journal-title":"Hepat Mon"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0186136","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-1063","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.01.004","article-title":"Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population","volume":"19","author":"Salva-Pastor","year":"2020","journal-title":"Ann Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.12.020","article-title":"Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"13","author":"Harsha Varma","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic Ovary Syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-10-56","article-title":"Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study","volume":"10","author":"Balkau","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0614","article-title":"Fatty liver index in polycystic ovary syndrome","volume":"165","author":"Lerchbaum","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1493","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis","volume":"13","author":"Polyzos","year":"2014","journal-title":"Hormones (Athens)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i4.149","article-title":"Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population","volume":"12","author":"Lind","year":"2020","journal-title":"World J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"B33","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"B34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents - an IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02597.x","article-title":"Sexual behavior and oral contraception: a pilot study","volume":"9","author":"Battaglia","year":"2012","journal-title":"J Sex Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12392","article-title":"Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study","volume":"11","author":"Battaglia","year":"2014","journal-title":"J Sex Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12284","article-title":"Body imaging and sexual behavior in lean women with polycystic ovary syndrome","volume":"10","author":"Morotti","year":"2013","journal-title":"J Sex Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12103","article-title":"Clitoral changes, sexuality, and body image during the menstrual cycle: a pilot study","volume":"10","author":"Morotti","year":"2013","journal-title":"J Sex Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12045","article-title":"Body mass index, Stunkard Figure Rating Scale, and sexuality in young Italian women: a pilot study","volume":"10","author":"Morotti","year":"2013","journal-title":"J Sex Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02257.x","article-title":"Cigarette smoking decreases the genital vascularization in young healthy, eumenorrheic women","volume":"8","author":"Battaglia","year":"2011","journal-title":"J Sex Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02310.x","article-title":"Moderate alcohol intake, genital vascularization, and sexuality in young, healthy, eumenorrheic women","volume":"8","author":"Battaglia","year":"2011","journal-title":"A Pilot Study J Sex Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00972.x","article-title":"Menstrual cycle-related morphometric and vascular modifications of the clitoris","volume":"5","author":"Battaglia","year":"2008","journal-title":"J Sex Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.01124.x","article-title":"Ultrasonographic and Doppler findings of subclinical clitoral microtraumatisms in mountain bikers and horseback riders","volume":"6","author":"Battaglia","year":"2009","journal-title":"J Sex Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01430.x","article-title":"The role of 3-D ultrasonography in the evaluation of menstrual cycle-related vascular modifications of the clitoris","volume":"6","author":"Battaglia","year":"2009","journal-title":"A Prospective Pilot Study J Sex Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01418.x","article-title":"Persistent genital arousal disorder and trazodone","volume":"6","author":"Battaglia","year":"2009","journal-title":"Morphometric Vasc Modif Clitoris A Case Rep J Sex Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01402.x","article-title":"Periovulatory morphometric and vascular modifications of the clitoris in young adult and middle-aged women","volume":"6","author":"Battaglia","year":"2009","journal-title":"A Pilot Study J Sex Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00699.x","article-title":"Sonography of the clitoris","volume":"5","author":"Buisson","year":"2008","journal-title":"J Sex Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12279","article-title":"Pilot echographic study of the differences in clitoral involvement following clitoral or vaginal sexual stimulation","volume":"10","author":"Buisson","year":"2013","journal-title":"J Sex Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1177\/00359157740676P113","article-title":"Arterial assessment by Doppler-shift ultrasound","volume":"67","author":"Gosling","year":"1974","journal-title":"Proc R Soc Med"},{"key":"B54","volume-title":"Critical care ultrasound","author":"Lumb","year":"2014"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105445","article-title":"Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease","volume":"194","author":"Salva-Pastor","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B56","article-title":"Sex Hormone Binding Globulin (SHBG) as a Marker of Clinical Disorders","volume":"40","author":"Gold\u0161tajn","year":"2016","journal-title":"Coll Antropol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00158","article-title":"Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PloS Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.09.009","article-title":"Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance","volume":"13","author":"Maseroli","year":"2016","journal-title":"J Sex Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2018.02.009","article-title":"Risk Factors and Potential Pathophysiological Underpinnings for Female Vasculogenic Sexual Dysfunction Syndromes","volume":"6","author":"Maseroli","year":"2018","journal-title":"Sex Med Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2018.03.004","article-title":"Understanding (and Overcoming) Gender Differences: The Key Role of an Adequate Methodological Approach","volume":"6","author":"Maseroli","year":"2018","journal-title":"Sex Med Rev"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1668","article-title":"Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development","volume":"158","author":"Saez-Lopez","year":"2017","journal-title":"Endocrinology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32249","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz244","article-title":"Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13530","article-title":"Sex hormone-binding globulin is associated with androgen deficiency features independently of total testosterone","volume":"88","author":"Rastrelli","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis","volume":"64","author":"Deswal","year":"2018","journal-title":"Syst Biol Reprod Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.09.010","article-title":"Sex hormone-binding globulin and polycystic ovary syndrome","volume":"499","author":"Zhu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2016_1252","article-title":"Hepatokines and non-alcoholic fatty liver disease","volume":"63","author":"Lebensztejn","year":"2016","journal-title":"Acta Biochim Pol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i44.9674","article-title":"Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV","volume":"22","author":"Lonardo","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.07.005","article-title":"Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases","volume":"41","author":"Motamed","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.01.005","article-title":"Adolescent oligomenorrhea (age 14-19) tracks into the third decade of life (age 20-28) and predicts increased cardiovascular risk factors and metabolic syndrome","volume":"64","author":"Glueck","year":"2015","journal-title":"Metabolism"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.641446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T17:13:22Z","timestamp":1617038002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.641446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":73,"alternative-id":["10.3389\/fendo.2021.641446"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.641446","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"article-number":"641446"}}